Related Experiment Video
Updated: Jun 3, 2026

Systems Biology of Metabolic Regulation by Estrogen Receptor Signaling in Breast Cancer
Published on: March 17, 2016
A feedback loop between androgen receptor and ERK signaling in estrogen receptor-negative breast cancer
Kee Ming Chia1, Ji Liu, Glenn D Francis
1University of Queensland Diamantina Institute, Princess Alexandra Hospital, Brisbane, Queensland, Australia.
Abstract:
Estrogen receptor (ER)-negative breast cancer is heterogeneous, and the biology of this disease has remained poorly understood. Molecular apocrine is a subtype of ER-negative breast cancer that is characterized by the overexpression of steroid-response genes such as AR and a high rate of ErbB2 amplification. In this study, we have identified a positive feedback loop between the AR and extracellular signal-regulated kinase (ERK) signaling pathways in molecular apocrine breast cancer. In this process, AR regulates ERK phosphorylation and kinase activity. In addition, AR inhibition results in the down-regulation of ERK target proteins phospho-RSK1, phospho-Elk-1, and c-Fos using an in vivo molecular apocrine model. Furthermore, we show that AR-mediated induction of ERK requires ErbB2, and AR activity, in turn, regulates ErbB2 expression as an AR target gene. These findings suggest that ErbB2 is an upstream connector between the AR and ERK signaling pathways. Another feature of this feedback loop is an ERK-mediated regulation of AR. In this respect, the inhibition of ERK phosphorylation reduces AR expression and CREB1-mediated transcriptional regulation of AR acts as a downstream connector between the AR and ERK signaling pathways in molecular apocrine cells. Finally, we demonstrate that AR-positive staining is associated with the overexpression of ERK signaling targets phospho-Elk-1 and c-Fos in ER-negative breast tumors, which further supports a cross-regulation between the AR and ERK signaling pathways in molecular apocrine subtype. This study demonstrates an AR-ERK feedback loop in ER-negative breast cancer with significant biologic and therapeutic implications in this disease.
Insights
Researchers discovered a feedback loop between androgen receptor (AR) and extracellular signal-regulated kinase (ERK) signaling in estrogen receptor-negative breast cancer. This AR-ERK pathway cross-regulation offers new therapeutic targets for this aggressive cancer subtype.
Area of Science:
- Oncology
- Molecular Biology
- Biochemistry
Background:
- Estrogen receptor (ER)-negative breast cancer is a heterogeneous disease with poorly understood biology.
- Molecular apocrine breast cancer, an ER-negative subtype, overexpresses androgen receptor (AR) and ErbB2.
Purpose of the Study:
- To investigate the relationship between AR and extracellular signal-regulated kinase (ERK) signaling pathways in molecular apocrine breast cancer.
- To elucidate the feedback mechanisms and therapeutic implications of the AR-ERK axis in this cancer subtype.
Main Methods:
- Utilized an in vivo molecular apocrine model to study AR and ERK pathway interactions.
- Examined the regulation of ERK phosphorylation and activity by AR.
- Assessed the role of ErbB2 as a mediator between AR and ERK signaling.
- Investigated ERK-mediated regulation of AR expression and downstream targets.
Main Results:
- Identified a positive feedback loop where AR regulates ERK phosphorylation and activity.
- Demonstrated that AR inhibition down-regulates ERK target proteins.
- Showed that AR-mediated ERK induction requires ErbB2, and AR regulates ErbB2 expression.
- Revealed ERK-mediated regulation of AR expression and identified CREB1 as a downstream connector.
- Found AR-positive staining associated with ERK signaling targets in ER-negative tumors.
Conclusions:
- Established a significant AR-ERK feedback loop in ER-negative breast cancer, specifically in the molecular apocrine subtype.
- Highlighted the crucial role of ErbB2 as an upstream connector in this feedback loop.
- Suggested that targeting the AR-ERK axis holds therapeutic potential for molecular apocrine breast cancer.
Related Concept Videos
Mitogens and the Cell Cycle
mTOR Signaling and Cancer Progression
The mTOR pathway or the...
mTOR Signaling and Cancer Progression
The mTOR pathway or the...
MAPK Signaling Cascades
Enzyme-linked Receptors
Neurotrophin (NT) receptors are a family of RTKs, including trkA, trkB, and trkC (tropomyosin-related kinase) receptors. TrkA is specific for nerve growth factor (NGF), neurotrophin-6, and neurotrophin-7. TrkB binds...
Enzyme-linked Receptors
Neurotrophin (NT) receptors are a family of RTKs, including trkA, trkB, and trkC (tropomyosin-related kinase) receptors. TrkA is specific for nerve growth factor (NGF), neurotrophin-6, and neurotrophin-7. TrkB binds...

